| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$10,992 ) |
| | 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS133037 | Quality Improvement in time to Treatment of Status Epilepticus (QuITT-SE) | 000 | 2 | NIH | 11/15/2024 | $0 |
| | 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01DK100866 | CUREGN 3.0 - Pediatric Nephrology Consortium - PCC | 001 | 12 | NIH | 11/4/2024 | $156,580 |
| | 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL161338 | 1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL) | 000 | 3 | NIH | 10/29/2024 | $0 |
| | 2025 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | 2B2CMS331798 | Integrated Care for Kids (InCK) | 05 | 5 | CMS | 11/6/2024 | $0 |
| | 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL145032 | Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes | 000 | 5 | NIH | 10/30/2024 | $0 |
| | 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01DK100866 | CUREGN 3.0 - Pediatric Nephrology Consortium - PCC | 000 | 11 | NIH | 11/4/2024 | -$156,580 |
| | 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08DK122119 | Urothelial IL-6 Signaling in the Host Defense Against Urinary Tract Infections | 000 | 5 | NIH | 10/17/2024 | $0 |
| | 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08DK122119 | Urothelial IL-6 Signaling in the Host Defense Against Urinary Tract Infections | 001 | 5 | NIH | 10/17/2024 | $0 |
| | 2025 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AR073908 | Alternative delivery of adeno-associated virus therapeutic vector for the treatment of neuromuscular disorders | 000 | 5 | NIH | 10/10/2024 | -$10,992 |
| | 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Childhood high-risk sarcoma derived human satellite (HSAT) and endogenous retroviral (ERV) RNAs in systemic immunosuppression and inflammation | 001 | 1 | NIH | 11/8/2024 | $0 |
| | 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Childhood high-risk sarcoma derived human satellite (HSAT) and endogenous retroviral (ERV) RNAs in systemic immunosuppression and inflammation | 004 | 1 | NIH | 11/12/2024 | $0 |
| | 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AR079774 | Chromatin remodeling gene therapy for FSHD using split-vector AAV SMCHD1 vectors | 000 | 2 | NIH | 11/4/2024 | $0 |
| | 2025 | 2022 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | CE147208 | Community Project Funding/Congressionally Directed Spending - Construction | 06 | 1 | HRSA | 10/3/2024 | $0 |
| | 2025 | 2021 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Childhood high-risk sarcoma derived human satellite (HSAT) and endogenous retroviral (ERV) RNAs in systemic immunosuppression and inflammation | 000 | 1 | NIH | 11/8/2024 | $0 |
| | 2025 | 2020 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Childhood high-risk sarcoma derived human satellite (HSAT) and endogenous retroviral (ERV) RNAs in systemic immunosuppression and inflammation | 003 | 1 | NIH | 11/11/2024 | $0 |
| | 2025 | 2019 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U54CA232561 | Childhood high-risk sarcoma derived human satellite (HSAT) and endogenous retroviral (ERV) RNAs in systemic immunosuppression and inflammation | 002 | 1 | NIH | 11/11/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $73,384,386 ) (Continued on the next page) |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H3348997 | EMSC Partnership Grants | 00 | 2 | HRSA | 3/21/2024 | $83,352 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 Children's Drive | Columbus | OH | 43205-2664 | FRANKLIN | USA | H3348997 | EMSC Partnership Grants | 01 | 2 | HRSA | 7/5/2024 | $107,298 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01DK135015 | Identify risk factors for type 2 diabetes in adolescents | 001 | 2 | NIH | 6/18/2024 | $77,659 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL171715 | PET/CT Imaging of Venous Thromboembolism in Pediatric, Adolescent, and Young Adult Oncology | 000 | 1 | NIH | 7/5/2024 | $583,381 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL166794 | 1/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease | 001 | 2 | NIH | 5/15/2024 | $0 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4B15471 | Poison Control Stabilization and Enhancement Program | 00 | 16 | HRSA | 8/27/2024 | $430,001 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL160935 | Developing Primary Care Algorithms for Early Identification of Young Women with von Willebrand Disease | 000 | 3 | NIH | 8/19/2024 | $505,561 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K01HL169493 | Development and Validation of an Equitable Computable Phenotype for Classifying Pediatric Sleep Deficiency in Electronic Health Records | 000 | 2 | NIH | 8/17/2024 | $159,375 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | P50MH127476 | The Center for Accelerating Suicide Prevention in Real-world Settings (ASPIRES) | 001 | 3 | NIH | 7/16/2024 | $2,841,660 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AR078395 | CRISPR-Cas13 gene therapy and RNA editing for Facioscapulohumeral muscular dystrophy (FSHD) | 000 | 4 | NIH | 7/16/2024 | $540,811 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AI186003 | Interrogating infant immune responses for diagnosis of congenital syphilis infection | 000 | 1 | NIH | 7/15/2024 | $210,600 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157491 | Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | 002 | 4 | NIH | 6/22/2024 | $51,324 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | F31HL176054 | Elucidating the cellular and molecular basis of LYST-mediated TEVG stenosis | 000 | 1 | NIH | 8/16/2024 | $44,667 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | F31CA278353 | Mechanisms of Synergy between Oncolytic Herpes Simplex Virus and Trabectedin in Pediatric Bone Sarcomas | 000 | 2 | NIH | 5/23/2024 | $37,193 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AA027502 | Therapeutic roles of hepatocyte exosomes in the liver | 001 | 5 | NIH | 5/22/2024 | $40,984 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UG1HD068278 | NICHD Neonatal Research Network (NRN) | 001 | 14 | NIH | 6/6/2024 | $1,526 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K01DK126991 | Defining the renal urothelium progenitor and its regulation during development and repair | 000 | 4 | NIH | 5/22/2024 | $145,295 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K01DK128379 | Contrasting roles for neutrophils and macrophages during acute pyelonephritis | 000 | 4 | NIH | 4/30/2024 | $143,568 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UG3OD035536 | Environmental Influences on Child Health Outcomes (ECHO) and Pregnancy in Ohio | 000 | 2 | NIH | 6/11/2024 | $1,773,117 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01FD007532 | Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND] | 000 | 2 | FDA | 5/8/2024 | $485,894 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 001 | 4 | NIH | 4/17/2024 | $34,546 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA247941 | Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy | 001 | 4 | NIH | 4/18/2024 | $23,992 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AR083252 | AAV mediated gene knockdown of PIK3C2B as a therapeutic strategy for X-linked myotubular myopathy and fatty liver disease | 000 | 2 | NIH | 6/3/2024 | $125,479 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI146581 | Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1) | 002 | 4 | NIH | 5/28/2024 | $50,535 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DK138101 | Targeting Tubular Mitochondrial Superoxide Dismutation in Cisplatin Renal Repair | 000 | 1 | NIH | 6/4/2024 | $628,987 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U0328844 | Pediatric Emergency Care Applied Research Network (PECARN) | 00 | 10 | HRSA | 8/29/2024 | $699,999 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K01MH127417 | Epidemiologic and Machine Learning Approaches to Frame Suicide Prevention Strategies Among Juvenile Justice Youth - 2021 | 000 | 3 | NIH | 5/8/2024 | $123,172 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UG1HD068278 | NICHD Neonatal Research Network (NRN) | 000 | 14 | NIH | 4/11/2024 | $13,745 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R56NS132781 | Determining Mechanisms of Cerebral Blood Flow and Metabolism Derangements in Pediatric Cerebral Malaria (FLOW) | 000 | 1 | NIH | 5/10/2024 | $20,000 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R56NS132781 | Determining Mechanisms of Cerebral Blood Flow and Metabolism Derangements in Pediatric Cerebral Malaria (FLOW) | 000 | 1 | NIH | 5/10/2024 | $470,977 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R00HL155843 | Lung Allograft Stem Cell Regeneration and Immune Destruction | 001 | 3 | NIH | 5/10/2024 | -$526 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R00HL155843 | Lung Allograft Stem Cell Regeneration and Immune Destruction | 000 | 3 | NIH | 5/10/2024 | $526 |
|
